Sandoz-Novartis – Orbit Program
Led transition support for a portfolio of 60+ commercial applications as part of the Novartis-to-Sandoz separation program, working in close coordination with the Migration Team and the Application Management Services (AMS) organization. Managed planning and execution activities required to transfer application ownership, support readiness, operational processes, and service continuity from the legacy Novartis environment to the future-state Sandoz organization.

Key responsibilities included coordinating cross-functional transition activities across business, technical, infrastructure, migration, and support teams; defining and tracking transition plans, milestones, dependencies, risks, and handover criteria; and ensuring alignment between cutover, migration, validation, and operational support streams. Acted as the central interface between project delivery teams and AMS, helping prepare support models, service documentation, knowledge transfer, access setup, incident and change processes, and post-transition governance.

Supported readiness for go-live and post-separation operations by driving issue resolution, facilitating decision-making, escalating risks, and ensuring that applications were transitioned with minimal disruption to business operations. Contributed to a structured and controlled handover approach across a complex multi-application landscape in a highly regulated pharmaceutical environment.
Sandoz (Novartis division) – SCOUT AMS Transition
Led the transition of application support for SCOUT (Sandoz Customer Ordering & Utility Tools) to a new Application Management Services (AMS) vendor. Managed the end-to-end transition process to ensure continuity of support, operational readiness, and controlled handover of responsibilities from the incumbent organization to the new support provider.
Coordinated transition activities across business stakeholders, application teams, vendor teams, and support functions. Defined and tracked the transition plan, milestones, deliverables, dependencies, and risks. Organized and oversaw knowledge transfer, service documentation handover, access provisioning, support process setup, governance alignment, and readiness checkpoints required for a stable transfer to the new AMS model.

Acted as the key interface between project, business, and support organizations, ensuring that the incoming vendor had the necessary functional, technical, and operational understanding of the solution landscape. Supported issue resolution, risk escalation, and decision-making throughout the transition period, while maintaining focus on service continuity and minimizing disruption to business operations.

Contributed to a structured and compliant handover approach in a complex international pharmaceutical environment, helping establish the foundation for stable post-transition support operations.
Sandoz (Novartis division) – SCOUT Global AMS Transition
Led the transition of SCOUT solution support to Application Management Services (AMS) across a large and complex international landscape covering major releases and deployment waves in more than 50 countries. Managed the transition from project-driven delivery into a sustainable support model, ensuring business continuity, operational readiness, and controlled handover of responsibilities across markets.

Coordinated transition activities across country teams, business stakeholders, project teams, release management, functional and technical experts, and AMS support organization. Planned and governed the handover approach for successive release cycles and rollout waves, aligning transition timelines with deployment plans, support readiness milestones, and market-specific requirements.

Key responsibilities included organizing knowledge transfer, preparing and validating support documentation, defining support processes and governance model, coordinating access and operational setup, and ensuring that the AMS team was ready to support both ongoing operations and upcoming releases. Managed dependencies, risks, and open issues across multiple countries and waves, and drove resolution in collaboration with the relevant business and technical stakeholders.

Served as the central coordination point between delivery and support organizations, helping ensure smooth stabilization after go-lives and effective transition of ownership into steady-state operations. Supported a structured handover model in a highly regulated pharmaceutical environment, enabling consistent support readiness across a broad global footprint.